Metabolism-driven Interactions Of Non-typeable Haemophilus Influenzae And Its Host: A Critical Factor In Infection?
Funder
National Health and Medical Research Council
Funding Amount
$474,932.00
Summary
Non-typeable Haemophilus influenzae (NTHi) is the underlying cause of many severe acute and chronic respiratory infections, which represent a significant burden to the healthcare system. As NTHi is unable to survive outside the human host, it is is highly adapted to survival in the body niches it colonizes. We are investigating how NTHI is able to survive in the presence of tissue inflammation, and whether it contributes to the inflammatory process through some of its metabolic products.
Impact Of Phasevarions Of Non-typeable Haemophilus Influenzae On Otitis Media Pathobiology And Vaccine Development.
Funder
National Health and Medical Research Council
Funding Amount
$613,124.00
Summary
Otitis media (OM), or middle ear infection, is a prevalent pediatric disease worldwide. Haemophilus influenzae causes 40% of acute OM cases, and most chronic OM and recurrent OM. There is a urgent need for vaccines to prevent OM. Our discovery of a novel genetic switch gives new insights into OM and the change from asymptomatic colonization to OM. The role of this switch on virulence in several dominant strains, and the impact on current and future candidates will be studied.
Evaluation Of Haemophilus Haemolyticus As A Preventative Therapy For NTHi Disease
Funder
National Health and Medical Research Council
Funding Amount
$445,659.00
Summary
Middle ear infections are the most common reason for a child to be given antibiotics and undergo surgery. This project will investigate whether a harmless bacterium found in the respiratory tract of children can be used as a probiotic to prevent bacterial ear infections. Benefits from reducing ear infections include fewer children undergoing surgery, fewer GP visits and antibiotic prescriptions, less time off work for parents, reduced hearing loss in children, and improved educational outcomes.
A Multi-centre, Double-blind, Randomised Controlled Trial To Evaluate The Efficacy Of 10 Valent-pneumococcal-Protein D Conjugate Vaccine In Reducing Respiratory Exacerbations In Children Aged ? 18 Months With Suppurative Lung Disease
Funder
National Health and Medical Research Council
Funding Amount
$1,160,660.00
Summary
Chronic suppurative (ie infected) lung diseases in children are major causes of poor health and deaths worldwide. Repeated childhood infections contribute to poor lung health in adults. The most common organism causing infection is non-typeable Haemophilus influenzae (NTHi). This study aims to determine whether a vaccine against NTHi can reduce repeated respiratory infections in children. If so, vaccination may lead to substantial improvements in current/ future lung health, and considerable dir ....Chronic suppurative (ie infected) lung diseases in children are major causes of poor health and deaths worldwide. Repeated childhood infections contribute to poor lung health in adults. The most common organism causing infection is non-typeable Haemophilus influenzae (NTHi). This study aims to determine whether a vaccine against NTHi can reduce repeated respiratory infections in children. If so, vaccination may lead to substantial improvements in current/ future lung health, and considerable direct and indirect cost of disease savings.Read moreRead less
Novel Epigenetic Regulatory Mechanisms In Moraxella Catarrhalis And Non-typeable Haemophilus Influenzae: Impact On Vaccine Development And Role In Pathobiology
Funder
National Health and Medical Research Council
Funding Amount
$626,979.00
Summary
Moraxella catarrhalis (Mcat) and non-typeable Haemophilus influenzae (NTHI) are two major causes of middle ear infections in children, and respiratory disease in adults. This project aims to characterise novel regulatory mechanisms associated with disease isolates of these bacteria. This research will aid vaccine development by defining the repertoire of stably expressed potential vaccine targets of Mcat and NTHi, and will improve our understanding of host-pathogen interactions.
Dynamics Of Haemophilus Haemolyticus And Nontypeable Haemophilus Influenzae Colonisation In Otitis-prone Children
Funder
National Health and Medical Research Council
Funding Amount
$358,790.00
Summary
A vaccine has been licenced that reduces ear disease. A harmless bacterium masquerades as the pathogen responsible for ear disease, nontypeable Haemophilus influenzae (NTHi), leading to inaccurate surveillance of ear disease. This project will measure the true proportion of NTHi in ears and noses to help policy decisions regarding the introduction of the vaccine to Western Australia. We will be able to assess the impact this vaccine has had in the Northern Territory since implementation in 2009.
Diseases caused by the pneumococcus represent the largest cause of vaccine preventable death in the world today, mainly pneumonia and meningitis. In 2011, 16 developing countries will introduce pneumococcal conjugate vaccines, none in east Asia. Lack of research has been a major barrier to their use in the region. We have established an international centre of excellence in the field and we seek support to extend the capacity of this group and to transfer the technology to Vietnam.
Genetic Dissection Of Biofilm Development By Non-typeable Haemophilus Influenzae
Funder
National Health and Medical Research Council
Funding Amount
$418,516.00
Summary
The bacterial pathogen non-typeable Haemophilus influenzae (NTHi) is a common cause of chronic infections of the middle ear and of the airways of patients suffering cystic fibrosis, or chronic obstructive pulmonary disease (COPD). These infections are associated with bacterial biofilms that are significantly resistant to both antibiotics and immune defences. This project aims to characterise the process of NTHi biofilm development so that novel diagnostic tools and therapeutics can be developed.
Phase Variable Protein Glycosylation In Bacteria Mucosal Pathogens And Its Role In Immune Evasion
Funder
National Health and Medical Research Council
Funding Amount
$409,728.00
Summary
The bacterium Haemophilus influenzae is a leading cause of ear infections. Hearing loss from these infections can seriously affect literacy and educational performance. As no vaccine is available, we will research how the bacterium makes the HMW protein that is important in infection. We will study how sugars are added to the surface of this protein so that the bacterium can escape the immune system, its role in related bacteria and how it may be used in a vaccine.